Gericke has introduced the GFS LAB system, designed to support the continuous manufacturing and formulation of oral solid dosage (OSD) forms in the pharmaceutical industry. This innovative system enhances product quality, reduces drug shortages, and shortens development times by allowing for efficient, small-scale production with minimal active pharmaceutical ingredient (API) consumption.

The GFS LAB system utilizes modular skid technology, enabling the production of new drugs during early development phases. Gericke offers a versatile portfolio of lab-sized equipment, including full- and semi-continuous blenders, as well as interchangeable feeders. This modular approach ensures flexibility, as the system can operate as an individual machine or be integrated with other equipment.

One of the key advantages of the GFS LAB system is its portability and compact design, making it ideal for fast, agile integration into any production environment. The system requires only a few grams of API for operation, making it both cost-effective and environmentally friendly. Additionally, it meets Code 21 Part 11 standards for data acquisition.

Gericke’s GFS LAB system offers advanced solutions for dry/wet granulation, capsule filling, and more, available for rent or on-site trials at Gericke’s global test centers, backed by extensive local support.

www.gerickegroup.com

Gericke Formulation Skid GFS LAB